Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
World Journal of Urology|March 20, 2024
PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?Fabian Falkenbach, Francesca Ambrosini, Mykyta Kachanov, et al.
Seminars in Radiation Oncology|June 14, 2025
Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy ApproachGunhild von Amsberg, Moritz Kaune, Anja Coym, et al.
European Urology Focus|February 28, 2026
Identification of Biomarkers Predictive of Successful Salvage Surgery in Prostate-specific Membrane Antigen Positron Emission Tomography-positive Oligorecurrent Prostate Cancer: Results from the BioPoP TrialSabine Riethdorf, Sophie Knipper, Fabian Falkenbach, et al.
World Journal of Urology|May 2, 2022
Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy coresSami-Ramzi Leyh-Bannurah, Svitlana Boiko, Dirk Beyersdorff, et al.
World Journal of Urology|January 20, 2024
Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patientsFabian Falkenbach, Mykyta Kachanov, Sami-Ramzi Leyh-Bannurah, et al.
World Journal of Urology|June 4, 2026
Efficacy of the optilume® drug-coated balloon for recurrent urethral stricture after prior urethroplasty: a 12-month multicenter follow-up studyGeorgi Tosev, Cornelius Geil-Bierschenk, Ivan Damgov, et al.
The Prostate|September 2, 2024
Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasoundFabian Falkenbach, Fatima Ahmad-Sterkau, Mykyta Kachanov, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 26, 2023
Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysisDaniel Koehler, Samuel Trappe, Farzad Shenas, et al.
Clinical & Experimental Metastasis|January 30, 2025
Incisional PSMA PET/CT-positive recurrences in prostate cancer- is there an implication on clinical care?Giovanni Mazzucato, Fabian Falkenbach, Jonas Ekrutt, et al.
The Prostate|October 9, 2024
Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancerFabian Falkenbach, Marie-Lena Schmalhofer, Zhe Tian, et al.
Pageof 9